• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

主动脉夹层的基因组医学现状与未来方向:走向预防与个体化医疗之路。

Current state and future directions of genomic medicine in aortic dissection: A path to prevention and personalized care.

机构信息

Division of Medical Genetics, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX.

McGovern Medical School, University of Texas Health Science Center, Houston, TX.

出版信息

Semin Vasc Surg. 2022 Mar;35(1):51-59. doi: 10.1053/j.semvascsurg.2022.02.003. Epub 2022 Feb 25.

DOI:10.1053/j.semvascsurg.2022.02.003
PMID:35501041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9258522/
Abstract

Aortic dissection confers high mortality and morbidity rates despite advances in treatment, impacts quality of life, and contributes immense burden to the healthcare system globally. Efforts to prevent aortic dissection through screening and management of modifiable risk factors and early detection of aneurysms should incorporate genomic information, as it is integral to stratifying risk. However, effective integration of genomic-guided risk assessment into clinical practice will require addressing implementation barriers that currently permeate our healthcare systems. The Aortic Dissection Collaborative was established to define aortic dissection research priorities through patient engagement. Using a collaborative patient-centered feedback model, our Genomic Medicine Working Group identified related research priorities that could be investigated by pragmatic interventional studies aimed at aortic dissection prevention, utilization of genomic information to improve patient outcomes, and access to genomic medicine services. Further research is also needed to identify the genomic, lifestyle, and environmental risk factors that contribute to aortic dissection so these data can be incorporated into future comparative effectiveness studies to prevent aortic dissection.

摘要

尽管在治疗方面取得了进展,但主动脉夹层的死亡率和发病率仍然很高,它影响生活质量,并给全球的医疗保健系统带来巨大负担。通过筛查和管理可改变的危险因素以及早期发现动脉瘤来预防主动脉夹层的努力应该纳入基因组信息,因为这是分层风险的关键。然而,要将基因组指导的风险评估有效纳入临床实践,就需要解决当前充斥我们医疗保健系统的实施障碍。主动脉夹层协作组织成立的目的是通过患者参与来确定主动脉夹层的研究重点。使用协作的以患者为中心的反馈模型,我们的基因组医学工作组确定了相关的研究重点,这些重点可以通过旨在预防主动脉夹层的实用干预性研究进行调查,包括利用基因组信息改善患者结局,以及获得基因组医学服务。还需要进一步研究确定导致主动脉夹层的基因组、生活方式和环境风险因素,以便将这些数据纳入未来的比较效果研究中,以预防主动脉夹层。

相似文献

1
Current state and future directions of genomic medicine in aortic dissection: A path to prevention and personalized care.主动脉夹层的基因组医学现状与未来方向:走向预防与个体化医疗之路。
Semin Vasc Surg. 2022 Mar;35(1):51-59. doi: 10.1053/j.semvascsurg.2022.02.003. Epub 2022 Feb 25.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Use of genetics for personalized management of heritable thoracic aortic disease: how do we get there?利用遗传学进行遗传性胸主动脉疾病的个性化管理:我们如何实现这一目标?
J Thorac Cardiovasc Surg. 2015 Feb;149(2 Suppl):S3-5. doi: 10.1016/j.jtcvs.2014.07.070. Epub 2014 Aug 5.
4
Type A Aortic Dissection in the United Kingdom: The Untold Facts.英国的 A 型主动脉夹层:未被讲述的事实。
Semin Thorac Cardiovasc Surg. 2019;31(4):664-667. doi: 10.1053/j.semtcvs.2019.06.011. Epub 2019 Jul 5.
5
Nonsyndromic Thoracic Aortic Aneurysms and Dissections-Is Screening Possible?非综合征性胸主动脉瘤和夹层:是否可行筛查?
Semin Thorac Cardiovasc Surg. 2019;31(4):628-634. doi: 10.1053/j.semtcvs.2019.05.035. Epub 2019 Jun 15.
6
Decision-making algorithm for ascending aortic aneurysm: Effectiveness in clinical application?升主动脉瘤决策算法:临床应用的有效性?
J Thorac Cardiovasc Surg. 2019 May;157(5):1733-1745. doi: 10.1016/j.jtcvs.2018.09.124. Epub 2018 Nov 14.
7
Stakeholder perspectives on education in aortic dissection.主动脉夹层教育的利益相关者观点。
Semin Vasc Surg. 2022 Mar;35(1):69-77. doi: 10.1053/j.semvascsurg.2022.02.002. Epub 2022 Feb 17.
8
The Aortic Dissection Collaborative: Methods for building capacity for patient-centered outcomes research in the aortic dissection community.主动脉夹层协作组:在主动脉夹层社区中建立以患者为中心的结局研究能力的方法。
Semin Vasc Surg. 2022 Mar;35(1):9-15. doi: 10.1053/j.semvascsurg.2022.02.004. Epub 2022 Feb 23.
9
Epidemiology of aortic dissection.主动脉夹层的流行病学。
Semin Vasc Surg. 2021 Mar;34(1):10-17. doi: 10.1053/j.semvascsurg.2021.02.003. Epub 2021 Feb 5.
10
Equity in Genomic Medicine.基因组医学中的公平性。
Annu Rev Genomics Hum Genet. 2022 Aug 31;23:613-625. doi: 10.1146/annurev-genom-112921-022635. Epub 2022 Apr 1.

引用本文的文献

1
Outcomes of Surgical Versus Conservative Management in Stanford Type a Aortic Dissection: A Single-Center Retrospective Study.斯坦福A型主动脉夹层手术治疗与保守治疗的疗效:一项单中心回顾性研究
Life (Basel). 2025 Mar 14;15(3):462. doi: 10.3390/life15030462.
2
Postoperative self-management experiences among patients with aortic dissection: a phenomenological approach.主动脉夹层患者术后自我管理体验:一种现象学方法
BMC Cardiovasc Disord. 2025 Jan 6;25(1):4. doi: 10.1186/s12872-024-04435-4.
3
Identification of Genetic Variants Associated with Hereditary Thoracic Aortic Diseases (HTADs) Using Next Generation Sequencing (NGS) Technology and Genotype-Phenotype Correlations.使用下一代测序(NGS)技术和基因型-表型相关性鉴定与遗传性胸主动脉疾病(HTADs)相关的遗传变异。
Int J Mol Sci. 2024 Oct 17;25(20):11173. doi: 10.3390/ijms252011173.
4
Identification of Variants of Uncertain Significance in the Genes Associated with Thoracic Aortic Disease in Russian Patients with Nonsyndromic Sporadic Subtypes of the Disorder.鉴定俄罗斯非综合征型散发性疾病患者与胸主动脉疾病相关基因中的意义未明变异。
Int J Mol Sci. 2024 Jul 30;25(15):8315. doi: 10.3390/ijms25158315.
5
Practice Patterns and Barriers to Vascular Genetic Testing Among Vascular Surgeons.血管外科医生进行血管遗传检测的实践模式和障碍。
Ann Vasc Surg. 2024 Aug;105:140-149. doi: 10.1016/j.avsg.2024.01.032. Epub 2024 Apr 8.
6
Emerging role of radiogenomics in genetically triggered thoracic aortic aneurysm and dissection: a narrative review.放射基因组学在基因引发的胸主动脉瘤和夹层中的新作用:一项叙述性综述
Ann Transl Med. 2023 Aug 30;11(10):356. doi: 10.21037/atm-22-6149. Epub 2023 Apr 17.
7
Familial Associations of Prevalence and Cause-Specific Mortality for Thoracic Aortic Disease and Bicuspid Aortic Valve in a Large-Population Database.基于大型人群数据库探讨胸主动脉疾病和二叶式主动脉瓣与患病率及病因特异性死亡率的家族关联性。
Circulation. 2023 Aug 22;148(8):637-647. doi: 10.1161/CIRCULATIONAHA.122.060439. Epub 2023 Jun 15.
8
Risk Factors for Thoracic Aortic Dissection.胸主动脉夹层的危险因素。
Genes (Basel). 2022 Oct 7;13(10):1814. doi: 10.3390/genes13101814.

本文引用的文献

1
The Aortic Dissection Collaborative: Methods for building capacity for patient-centered outcomes research in the aortic dissection community.主动脉夹层协作组:在主动脉夹层社区中建立以患者为中心的结局研究能力的方法。
Semin Vasc Surg. 2022 Mar;35(1):9-15. doi: 10.1053/j.semvascsurg.2022.02.004. Epub 2022 Feb 23.
2
Development and Validation of a Predictive Model to Identify Patients With an Ascending Thoracic Aortic Aneurysm.升主动脉瘤患者预测模型的建立与验证。
J Am Heart Assoc. 2021 Nov 16;10(22):e022102. doi: 10.1161/JAHA.121.022102. Epub 2021 Nov 6.
3
Physicians' strategies for using family history data: having the data is not the same as using the data.医生使用家族病史数据的策略:拥有数据并不等同于使用数据。
JAMIA Open. 2020 Oct 8;3(3):378-385. doi: 10.1093/jamiaopen/ooaa035. eCollection 2020 Oct.
4
Efficacy of a family-based cardiovascular risk reduction intervention in individuals with a family history of premature coronary heart disease in India (PROLIFIC): an open-label, single-centre, cluster randomised controlled trial.基于家庭的心血管风险降低干预在印度有早发性冠心病家族史个体中的效果(PROLIFIC):一项开放标签、单中心、集群随机对照试验。
Lancet Glob Health. 2021 Oct;9(10):e1442-e1450. doi: 10.1016/S2214-109X(21)00319-3.
5
Impact of a multidisciplinary acute aortic dissection program: Improved outcomes with a comprehensive initial surgical repair strategy.多学科急性主动脉夹层项目的影响:采用综合初始外科修复策略可改善结局。
J Vasc Surg. 2022 Feb;75(2):484-494.e1. doi: 10.1016/j.jvs.2021.08.058. Epub 2021 Sep 8.
6
Uptake of Screening and Recurrence of Bicuspid Aortic Valve and Thoracic Aortic Aneurysm Among At-Risk Siblings of Pediatric Probands.高危儿科先证者的二叶式主动脉瓣和胸主动脉瘤的兄弟姐妹的筛查接受率和复发率。
J Pediatr. 2021 Dec;239:219-224. doi: 10.1016/j.jpeds.2021.08.013. Epub 2021 Aug 14.
7
Genetic testing in ambulatory cardiology clinics reveals high rate of findings with clinical management implications.门诊心脏病学诊所的基因检测显示出具有临床管理意义的高发现率。
Genet Med. 2021 Dec;23(12):2404-2414. doi: 10.1038/s41436-021-01294-8. Epub 2021 Aug 6.
8
Considerations for Cardiovascular Genetic and Genomic Research With Marginalized Racial and Ethnic Groups and Indigenous Peoples: A Scientific Statement From the American Heart Association.边缘化种族和族裔群体以及原住民的心血管遗传和基因组研究的考虑因素:美国心脏协会的科学声明。
Circ Genom Precis Med. 2021 Aug;14(4):e000084. doi: 10.1161/HCG.0000000000000084. Epub 2021 Jul 26.
9
Cost-effectiveness analysis of screening for first-degree relatives of patients with bicuspid aortic valve.对二叶式主动脉瓣患者一级亲属进行筛查的成本效益分析。
Eur Heart J Qual Care Clin Outcomes. 2021 Sep 16;7(5):447-457. doi: 10.1093/ehjqcco/qcab047.
10
The Many Care Models to Treat Thoracic Aortic Disease in Canada: A Nationwide Survey of Cardiac Surgeons, Cardiologists, Interventional Radiologists, and Vascular Surgeons.加拿大治疗胸主动脉疾病的多种护理模式:一项针对心脏外科医生、心脏病专家、介入放射科医生和血管外科医生的全国性调查。
CJC Open. 2021 Feb 11;3(6):787-800. doi: 10.1016/j.cjco.2021.02.005. eCollection 2021 Jun.